ESGO eAcademy, The Official eLearning Portal of the European Society of Gynaecological Oncology

Create Account Sign In
slider image
Login now to access Regular content available to all registered users.
Click here to create a free account.

Access to Premium content is currently a membership benefit.

Click here to join ESGO or renew your membership.
1.1 LECTURE
Discussion Forum (0)
Code of conduct/disclaimer available in General Terms & Conditions
Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer - Results of NRG Oncology/Gynecologic Oncology Group study GOG-0213: a multicentre, open-label, randomised, phase 3 trial
Prof. Dr. Robert L Coleman
Prof. Dr. Robert L Coleman
ESGO eAcademy. Coleman R. 01/29/2020; 288002; Topic: Clinical trials
user
Prof. Dr. Robert L Coleman
Discussion Forum (0)
Code of conduct/disclaimer available in General Terms & Conditions
ESGO Activities

What's new

Join ESGO 2025 Congress:the largest European Gathering in Gynaecological Cancers!
ESGO 2025 will be a celebration of discovery and late-breaking research, new guidelines, practical demonstrations, and exclusive live surgery transmissions from hospitals you don't want to miss.

GDPR Notice

By participating in the activities at ESGO eAcademy you have agreed to our Data Protection Principles.

About Us

ESGO eAcademy, the official knowledge portal of ESGO, is a powerful resource featuring a wide range of educational content developed by the European Society of Gynaecological Oncology over the years. ESGO Members and premium subscribers can access hundreds of educational resources by topic, speaker, event: Congress Webcasts / Podcasts, Learning Quizzes, eLectures, eCourses, and Postgraduate Surgical Videos
2025 ©
European Society of Gynaecological Oncology
USER TERMS AND CONDITIONS / PRIVACY POLICY
(Amended according to GDPR)

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies